Robert Dufour

8.9k total citations · 4 hit papers
115 papers, 5.0k citations indexed

About

Robert Dufour is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Robert Dufour has authored 115 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Surgery, 20 papers in Endocrinology, Diabetes and Metabolism and 17 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Robert Dufour's work include Lipoproteins and Cardiovascular Health (52 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers) and Cancer, Lipids, and Metabolism (13 papers). Robert Dufour is often cited by papers focused on Lipoproteins and Cardiovascular Health (52 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers) and Cancer, Lipids, and Metabolism (13 papers). Robert Dufour collaborates with scholars based in Canada, United States and France. Robert Dufour's co-authors include Judith F. Kroll, Daniel Gaudet, Alexis Baass, Evan A. Stein, Traci Turner, Robert Pordy, John J.P. Kastelein, Martine Paquette, Jean Davignon and Gisle Langslet and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Robert Dufour

107 papers receiving 4.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol

2017 738 citations Robert Dufour, Traci Turner et al. profile →
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial

2014 562 citations Frederick J. Raal, Evan A. Stein et al. The Lancet profile →
Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial

2012 463 citations Evan A. Stein, Jean Bergeron et al. The Lancet profile →
ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia

2015 418 citations John J.P. Kastelein, Henry N. Ginsberg et al. European Heart Journal profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Robert Dufour	3.0k	928	883	748	717	115	5.0k
Michael S. Watson	610 0.2×	201 0.2×	174 0.2×	1.2k 1.6×	413 0.6×	115	9.7k
Dana C. Crawford	350 0.1×	145 0.2×	364 0.4×	268 0.4×	504 0.7×	151	5.9k
Fernando Civeira	4.9k 1.6×	1.0k 1.1×	2.4k 2.7×	1.4k 1.8×	1.9k 2.7×	286	8.0k
Katrina A.B. Goddard	422 0.1×	170 0.2×	47 0.1×	426 0.6×	361 0.5×	135	5.0k
Kathryn L. Lunetta	335 0.1×	119 0.1×	339 0.4×	509 0.7×	1.1k 1.5×	198	7.0k
Ralph McGinnis	363 0.1×	128 0.1×	580 0.7×	74 0.1×	350 0.5×	25	4.5k
Sekar Kathiresan	1.4k 0.5×	181 0.2×	884 1.0×	456 0.6×	1.9k 2.6×	74	6.4k
Lina Jansen	900 0.3×	342 0.4×	110 0.1×	862 1.2×	183 0.3×	194	7.3k
Mark Bond	311 0.1×	88 0.1×	76 0.1×	1.1k 1.5×	254 0.4×	61	3.8k
Michelino De Laurentiis	590 0.2×	72 0.1×	256 0.3×	3.3k 4.4×	336 0.5×	333	10.7k

Countries citing papers authored by Robert Dufour

Since Specialization

Citations

This map shows the geographic impact of Robert Dufour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Dufour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Dufour more than expected).

Fields of papers citing papers by Robert Dufour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Dufour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Dufour. The network helps show where Robert Dufour may publish in the future.

Co-authorship network of co-authors of Robert Dufour

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Dufour. A scholar is included among the top collaborators of Robert Dufour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Dufour. Robert Dufour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Preston, Mark, Ramin Ebrahimi, Raj Desai, et al.. (2024). Risk of cardiovascular events following intermittent and continuous androgen deprivation therapy in patients with nonmetastatic prostate cancer. Urologic Oncology Seminars and Original Investigations. 42(12). 447.e1–447.e9. 2 indexed citations

Dufour, Robert, et al.. (2022). Treatment Patterns in Patients with Uterine Fibroids With and Without a Diagnosis of Heavy Menstrual Bleeding: Results from a Large U.S. Claims Database. Journal of Women s Health. 32(3). 332–340. 5 indexed citations

Dufour, Robert, et al.. (2021). PIH39 Treatment Patterns in Uterine Fibroid Patients Without a Claims Diagnosis of Heavy Menstrual Bleeding (HMB). Value in Health. 24. S105–S105.

Veenhuyzen, David van, et al.. (2020). PCN194 Prevalence of Major Adverse Cardiac Events (MACE) in Patients with Prostate Cancer (PC) Receiving Androgen Deprivation Therapy (ADT) in the United States. Value in Health. 23. S457–S457.

Dufour, Robert, et al.. (2018). PCN131 - ASSESSING THE REAL-WORLD COST OF CARE IN PATIENTS WITH METASTATIC TRIPLE NEGATIVE BREAST CANCER (MTNBC) IN THE UNITED STATES. Value in Health. 21. S36–S36. 2 indexed citations

Farnier, Michel, G. Kees Hovingh, Gisle Langslet, et al.. (2018). Long-term safety and efficacy of alirocumab in patients with heterozygous familial hypercholesterolemia: An open-label extension of the ODYSSEY program. Atherosclerosis. 278. 307–314. 45 indexed citations

Paquette, Martine, Yascara Grisel Luna Saavedra, Ann Chamberland, et al.. (2017). Association Between Plasma Proprotein Convertase Subtilisin/Kexin Type 9 and the Presence of Metabolic Syndrome in a Predominantly Rural-Based Sub-Saharan African Population. Metabolic Syndrome and Related Disorders. 15(8). 423–429. 13 indexed citations

Wassef, Hanny, et al.. (2017). Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women. Journal of Nutrition. 147(5). 754–762. 5 indexed citations

Cloutier, Lyne, Ghislaine O. Roederer, Paul Nguyen, et al.. (2017). Comparison of Different Automated Office Blood Pressure Measurement Devices: Evidence of Nonequivalence and Clinical Implications. Canadian Journal of Cardiology. 33(12). 1639–1644. 17 indexed citations

10.

Kastelein, John J.P., Henry N. Ginsberg, Gisle Langslet, et al.. (2015). ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia. European Heart Journal. 36(43). ehv370–ehv370. 418 indexed citations breakdown →

11.

Raal, Frederick J., Evan A. Stein, & Robert Dufour. (2015). PCSK9 Inhibition With Evolocumab (AMG 145) in Heterozygous Familial Hypercholesterolemia (RUTHERFORD-2): A Randomised, Double-Blind, Placebo-Controlled Trial. Journal of Vascular Surgery. 62(5). 1368–1368. 5 indexed citations

12.

Harrow, B., et al.. (2015). Health-care costs of asthma are lower using mp29-02* vs. Sequential sprays for allergic rhinitis. Value in Health. 18(3). A172–A173. 1 indexed citations

13.

Awan, Zuhier, Geneviève Dubuc, May Faraj, et al.. (2014). The effect of insulin on circulating PCSK9 in postmenopausal obese women. Clinical Biochemistry. 47(12). 1033–1039. 47 indexed citations

14.

Dufour, Robert, et al.. (2014). A Chart Abstraction Based Method to Classify Real World Patients With Pulmonary Arterial Hypertension Based on Who Functional Classification. Value in Health. 17(7). A547–A547. 1 indexed citations

15.

Stein, Evan A., Jean Bergeron, Daniel Gaudet, et al.. (2014). ONE YEAR OPEN-LABEL TREATMENT WITH ALIROCUMAB 150 MG EVERY TWO WEEKS IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIC PATIENTS. Journal of the American College of Cardiology. 63(12). A1371–A1371. 5 indexed citations

16.

Raal, Frederick J., Evan A. Stein, Robert Dufour, et al.. (2014). PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial. The Lancet. 385(9965). 331–340. 562 indexed citations breakdown →

17.

Dufour, Robert, Patrick M. Moriarty, Elisabeth Genestin, et al.. (2012). Abstract 16127: Effect of REGN727/SAR236553 Anti-Proprotein Convertase Subtilisin/Kexin Type 9 Fully Human Monoclonal Antibody in Patients with Elevated Triglycerides/Low High-Density Lipoprotein Cholesterol: Data from Three Phase 2 Studies (NCT:01266876; 01288469; 01288443). Circulation. 126. 2 indexed citations

18.

Kasivisvanathan, Veeru, Robert Dufour, Caroline M. Moore, et al.. (2012). Transperineal Magnetic Resonance Image Targeted Prostate Biopsy Versus Transperineal Template Prostate Biopsy in the Detection of Clinically Significant Prostate Cancer. The Journal of Urology. 189(3). 860–866. 164 indexed citations

19.

Goyard, E., et al.. (2007). Sécurisation des souches de crevettes d’élevage en Nouvelle-Calédonie. Résultats de la quarantaine et du conservatoire expérimental. Eléments pour la définition d’une stratégie de sécurisation des souches de crevettes en Nouvelle-Calédonie. Institutional Archive of Ifremer (French Research Institute for Exploitation of the Sea).

20.

Pasquale, Margaret K., Robert Dufour, Ashish V. Joshi, et al.. (1986). Inefficiencies in osteoarthritis and chronic low back pain management.. PubMed. 19(10). 259–23. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact